Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSL2000111	注射用重组人凝血因子VIII Fc-血管性血友病因子-XTEN融合蛋白	Lyophilized	Biological Products	Import Drug Application	2020-07-06	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd;Bioverativ Therapeutics Inc	In Review	2020-07-04	view
JXSL2000115	注射用重组人凝血因子VIII Fc-血管性血友病因子-XTEN融合蛋白	Lyophilized	Biological Products	Import Drug Application	2020-07-06	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd;Bioverativ Therapeutics Inc	In Review	2020-07-04	view
JXSL2000114	注射用重组人凝血因子VIII Fc-血管性血友病因子-XTEN融合蛋白	Lyophilized	Biological Products	Import Drug Application	2020-07-06	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd;Bioverativ Therapeutics Inc	In Review	2020-07-04	view
JXSL2000113	注射用重组人凝血因子VIII Fc-血管性血友病因子-XTEN融合蛋白	Lyophilized	Biological Products	Import Drug Application	2020-07-06	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd;Bioverativ Therapeutics Inc	In Review	2020-07-04	view
JXSL2000112	注射用重组人凝血因子VIII Fc-血管性血友病因子-XTEN融合蛋白	Lyophilized	Biological Products	Import Drug Application	2020-07-06	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd;Bioverativ Therapeutics Inc	In Review	2020-07-04	view
JXSL2000116	注射用重组人凝血因子VIII Fc-血管性血友病因子-XTEN融合蛋白	Lyophilized	Biological Products	Import Drug Application	2020-07-06	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd;Bioverativ Therapeutics Inc	In Review	2020-07-04	view